Creatine Kinase

Creatine Kinase (CK), also known as creatine phosphokinase (CPK), is an enzyme found primarily in skeletal muscle, cardiac muscle, and the brain. When muscle cells are damaged or stressed, CK is released into the bloodstream, making it a useful marker for muscle injury, inflammation, and overtraining.

CK exists in three isoforms: CK-MM (predominantly from skeletal muscle), CK-MB (predominantly from cardiac muscle), and CK-BB (predominantly from brain tissue). Standard CK blood tests measure total CK, which is overwhelmingly CK-MM in most contexts. Specific isoform testing may be requested if cardiac damage is suspected.

CK levels are significantly influenced by physical activity, with intense exercise commonly causing elevations that can persist for 24–72 hours. Race, sex, and muscle mass also affect baseline CK levels, with males and individuals with greater muscle mass typically having higher resting values.

CK is a valuable biomarker for anyone engaged in regular exercise or sport, as it provides objective insight into muscle recovery status. Persistently elevated CK may indicate overtraining, inadequate recovery, or underlying muscle pathology.

For longevity and health monitoring, CK helps detect conditions that damage muscle tissue, including myositis (inflammatory muscle disease), rhabdomyolysis (severe muscle breakdown), thyroid disorders, and certain genetic conditions such as muscular dystrophy.

CK is also relevant to cardiovascular health. While total CK elevation is most commonly of skeletal muscle origin, significantly raised CK in the context of chest pain may prompt CK-MB or troponin testing to assess for cardiac damage. Additionally, some cholesterol-lowering medications can cause muscle damage that CK monitoring can detect early.

Creatine kinase (CK) is released from damaged muscle cells and is the primary blood marker of muscle injury and exercise-induced muscle damage. CK is one of the most wearable-relevant biomarkers: your exercise data directly predicts CK levels. Eccentric exercise (downhill running, heavy negatives in resistance training), novel exercise, and extreme endurance efforts all produce dramatic CK elevations visible 24-72 hours post-exercise.

Your wearable's training load data provides essential context for interpreting CK. Levels can rise 5-50 times above baseline after intense exercise, which is a normal physiological response and not pathological. However, extremely elevated CK with dark urine, muscle swelling, and declining performance on your wearable may indicate rhabdomyolysis, which requires urgent medical attention.

Tracking CK alongside wearable recovery metrics (HRV, resting heart rate, sleep quality) helps optimise training. Persistent CK elevation combined with declining HRV and poor wearable recovery scores suggests accumulated muscle damage from insufficient recovery between training sessions. Adjusting training intensity and rest periods based on this combined data supports safer, more effective training progression.